CAH - Cardinal Health Inc. (CAH) Q3 2024 Earnings Call Transcript
2024-05-02 12:17:05 ET
Cardinal Health, Inc. (CAH)
Q3 2024 Earnings Conference Call
May 2, 2024 08:30 AM ET
Company Participants
Matt Sims - VP, IR
Jason Hollar - CEO
Aaron Alt - CFO
Conference Call Participants
Lisa Gill - JP Morgan
Michael Cherny - Leerink Partners
George Hill - Deutsche Bank
Allen Lutz - Bank of America
Kevin Caliendo - UBS
Eric Percher - Nephron Research
Stephanie Davis - Barclays
Eric Coldwell - Baird
Elizabeth Anderson - Evercore ISI
Stephen Baxter - Wells Fargo
Lucas Romanski - TD Cowen
Daniel Grosslight - Citi
Presentation
Operator
Hello, and welcome to the Third Quarter Fiscal Year 2024 Cardinal Health Incorporated Earnings Conference Call. My name is George. I'll be your coordinator for today's event. Please note, this conference is being recorded and for the duration of the call, your lines will be in a listen-only mode. [Operator Instructions]
I'd like to turn the call over to your host today, Matt Sims, Vice President, Investor Relations. Please go ahead, sir.
Matt Sims
Welcome to this morning's Cardinal Health third quarter fiscal '24 earnings conference call, and thank you for joining us. With me today are Cardinal Health's CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning's earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in the statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statements slide at the beginning of our presentation for a description of these risks and uncertainties.
Please note that during our discussion today, the comments will be on a non-GAAP basis, unless specifically called out as GAAP. GAAP to non-GAAP reconciliations for all relevant periods can be found in the supporting schedules attached to our press release. For the Q&A portion of today's call, we kindly ask that you limit questions to one per participant, so that we can try and give everyone an opportunity.
With that, I'll now turn the call over to Jason.
Jason Hollar
Good morning, everyone. A year ago at our Investor Day, I reflected upon what attracted me to Cardinal Health, our strong culture, values, and mission to be healthcare's most trusted partner; how the company was uniquely positioned with its breadth and scale to navigate the complexities of the healthcare ecosystem and serve the needs of customers, manufacturers and ultimately, patients.
At the same time, I was open about some of the opportunities in front of us as an organization. Together, we laid out a clear but aggressive strategic plan, streamlined our focus, and the team got to work, all the time prioritizing on our core business to emerge as a stronger, more resilient company. And we have a recent proof-point. Over the last several months, we deeply focused on preparing for a variety of alternatives regarding a particular large, low margin customer contract, which has allowed us to quickly navigate the upcoming contract change and confirm that we expect to grow our earnings in fiscal '25.
By driving improvements in our core operations, investing to expand our offerings in key areas like specialty and evolving our commercial approach in ways which have resonated elsewhere in the marketplace, we demonstrated that we have made progress on positioning our business for sustained success and growth. As we look ahead, the current quarter's results reinforce our confidence. We're operating from a position of growing strength and resiliency, with industry trends that remain stable and in our favor....
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript